Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05877638Terminated
Randomised, open-label trial (2 arms), sponsored by Synedgen. Primary endpoint: Percentage of healing wound progress up to 21 days. Started Mar 2023; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05877638.